Apixaban or Enoxaparin After Head and Neck Cancer Surgery

NCT07189897 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

76

Enrollment

OTHER

Sponsor class

Conditions

Venous Thromboembolism
Head and Neck Cancer

Interventions

DRUG: Enoxaparin
DRUG: Apixaban

Sponsor

Kiranya Arnold

Collaborators

[object Object]